Quick Search 
Drugs of the Future
Register or sign in

  
 
  
Volume 20, Issue 1, January 1995

MONOGRAPHS

Alkasar-18. Antineoplastic. R.A. Schwendener et al.

Ioxilan. Non-ionic contrast medium. J. Prous, N. Mealy, J. Castañer

Roquinimex. Immunomodulator. C. Robinson, J. Castañer

VAQTA™. Hepatitis A vaccine, purified inactivated. D.R. Nalin

ZD-1033. Aromatase inhibitor. J. Prous, N. Mealy, J. Castañer

Zopolrestat. Symptomatic antidiabetic, Aldose reductase inhibitor. J. Prous, N. Mealy, J. Castañer

REVIEW ARTICLES

Medicinal chemistry of muscarinic agonists: developments since 1990: Ejner K. Moltzen and Berith Bjornholm

2,3,6-Substituted quinazolinones as angiotensin II receptor antagonists: Jeremy I. Levin, Peter S. Chan and R. Stephen Porter

Information Update 1-19
AD-5423
Aranidipine
Artemisinin
Atevirdine Mesylate
BM-21.0955 Monosodium Salt Monohydrate
Brequinar Sodium
Calcipotriol
Cefcanel Daloxate Hydrochloride
CI-959
CL-316243
Cystemustine
Decitabine
Dexmedetomidine
DHAC
Didemnin B
Didox
E-2020
Edobacomab
Etodolac
Famotidine
Fazarabine
Fenoldopam Mesylate
FK-409
Flesinoxan Hydrochloride
Fludarabine Phosphate
Fluoxetine Hydrochloride
HGP-30
Lonapalene
Losulazine Hydrochloride
Loxiglumide
MCI-196
ME-3407
Milnacipran Hydrochloride
Mildronate
Nabumetone
Naftopidil
Nebracetam Fumarate
Nefiracetam
Otenzepad
Paclitaxel
Preclamol
Rabeprazole Sodium
Rolipram
Sebriplatin
SM-10888
SPR-901
Suritozole
Terazosin Hydrochloride
Tranilast
Vesnarinone
YM-060
Zaprinast
Zenarestat


 
  



© 2020 Clarivate Analytics. All rights reserved.
Copyright NoticeTerms of UsePrivacy StatementCookie Policy